Nanostructured lipid carriers for site-specific drug delivery
The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
Nanostructured lipid carriers (NLC), comprises of a blend of solid and liquid lipids which results in a partially crystallized lipid system and imparts many advantages over solid lipid nanoparticles such as enhanced drug loading capacity, drug release modulation flexibility and improved stability. NLC have found numerous applications in both pharmaceutical and cosmetic industry due to ease of preparation, the feasibility of scale-up, biocompatibility, non-toxicity, enhanced targeting efficiency and the possibility of site-specific delivery via various routes of administration. This review highlights the NLC with focus on the structure, the various fabrication techniques used and the characterization techniques which are critical in the development of a suitable and stable formulation. The review also provides an insight into the potential of NLC as site-specific delivery systems and the therapeutic applications explored via various routes of administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogels for biomedical applications
Hoffman, A. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00239-3 · Cited by 4,864
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Hydrogels for biomedical applications
Hoffman, A. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.010 · Cited by 3,396
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Hydrogel nanoparticles in drug delivery
Hamidi, M., Azadi, A., & Rafiei, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.002 · Cited by 2,067
Applications of Carbon Nanotubes in Drug Delivery
Kaur, J., Gill, G. S., & Jeet, K. (2019) · Characterization and Biology of Nanomaterials for Drug Delivery · doi:10.1016/b978-0-12-814031-4.00005-2 · Cited by 2,019
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application
Naseri, N., Valizadeh, H., & Zakeri-Milani, P. (2015) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2015.043 · Cited by 1,116
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,000
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Ocular drug delivery systems: An overview
Patel, A. (2013) · World Journal of Pharmacology · doi:10.5497/wjp.v2.i2.47 · Cited by 890
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Nano-niosomes as nanoscale drug delivery systems: An illustrated review
Moghassemi, S., & Hadjizadeh, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.015 · Cited by 797
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Polymeric nanoparticles for targeted drug delivery system for cancer therapy
Masood, F. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.11.067 · Cited by 702
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules
Tamjidi, F., Shahedi, M., Varshosaz, J., & Nasirpour, A. (2013) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2013.03.002 · Cited by 689
The importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594
Das, S., Ng, W. K., & Tan, R. B. H. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.05.010 · Cited by 576
Weber, S., Zimmer, A., & Pardeike, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.013 · Cited by 568
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
Tapeinos, C., Battaglini, M., & Ciofani, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.033 · Cited by 539
Fang, J.-Y., Fang, C.-L., Liu, C.-H., & Su, Y.-H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.008 · Cited by 518
Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q., & Zeng, S. (2005) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2005.08.005 · Cited by 511
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Nanomedicine in pulmonary delivery
Mansour, H., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 485
Freitas, C., & Müller, R. H. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00074-5 · Cited by 483
A holistic approach to targeting disease with polymeric nanoparticles
Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4503 · Cited by 480
Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C., & Mäder, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.012 · Cited by 472
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Paranjpe, M., & Müller-Goymann, C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 454
Schubert, M. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00130-3 · Cited by 454
Nanostructured lipid carriers system: Recent advances in drug delivery
Iqbal, M. A., Md, S., Sahni, J. K., Baboota, S., Dang, S., & Ali, J. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.716845 · Cited by 436
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Nanostructured lipid carriers and their current application in targeted drug delivery
Jaiswal, P., Gidwani, B., & Vyas, A. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.909822 · Cited by 406
Progress in brain targeting drug delivery system by nasal route
Khan, A. R., Liu, M., Khan, M. W., & Zhai, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.001 · Cited by 402
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Battaglia, L., & Gallarate, M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.673278 · Cited by 400
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Reis, S., Neves, Lúcio, Martins, & Lima (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s37840 · Cited by 368
Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
Fang, C.-L., A. Al-Suwayeh, S., & Fang, J.-Y. (2013) · Recent Patents on Nanotechnology · doi:10.2174/187221013804484827 · Cited by 367
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Progress in nanoparticles characterization: Sizing and zeta potential measurement
Xu, R. (2008) · Particuology · doi:10.1016/j.partic.2007.12.002 · Cited by 344
Kovacevic, A., Savic, S., Vuleta, G., Müller, R. H., & Keck, C. M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.036 · Cited by 342
Abdelkader, H., Alani, A. W. G., & Alany, R. G. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838077 · Cited by 341
BUNJES, H., & UNRUH, T. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.013 · Cited by 336
Teeranachaideekul, V., Souto, E. B., Junyaprasert, V. B., & Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.015 · Cited by 323
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
(2016) · Springer eBooks · doi:10.1007/978-3-319-15338-4 · Cited by 304
Nanostructured lipid carrier (NLC) based gel of celecoxib
Joshi, M., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.060 · Cited by 302
Lin, C.-H., Chen, C.-H., Lin, Z.-C., & Fang, J.-Y. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2017.02.001 · Cited by 298
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.032 · Cited by 263
Preparation of solid lipid nanoparticles using a membrane contactor
Charcosset, C., El-Harati, A., & Fessi, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.023 · Cited by 250
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
Madane, R. G., & Mahajan, H. S. (2016) · Drug Delivery · doi:10.3109/10717544.2014.975382 · Cited by 241
Muntimadugu, E., Dhommati, R., Jain, A., Challa, V. G. S., Shaheen, M., & Khan, W. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.012 · Cited by 240
SCHWARZ, C. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289185 · Cited by 235
Luo, Q., Zhao, J., Zhang, X., & Pan, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.013 · Cited by 234
Shah, N. V., Seth, A. K., Balaraman, R., Aundhia, C. J., Maheshwari, R. A., & Parmar, G. R. (2016) · Journal of Advanced Research · doi:10.1016/j.jare.2016.03.002 · Cited by 223
Lipid Nanoparticles: Production, Characterization and Stability
Shah, R., Eldridge, D., Palombo, E., & Harding, I. (2015) · SpringerBriefs in Pharmaceutical Science & Drug Development · doi:10.1007/978-3-319-10711-0 · Cited by 219
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC
Teeranachaideekul, V., Boonme, P., Souto, E. B., Müller, R. H., & Junyaprasert, V. B. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.011 · Cited by 215
Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules
Fortuna, A., Alves, G., Serralheiro, A., Sousa, J., & Falcão, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.004 · Cited by 211
SLN and NLC for topical delivery of ketoconazole
Souto, E. B., & Müller, R. H. (2005) · Journal of Microencapsulation · doi:10.1080/02652040500162436 · Cited by 208
Stability of lipid excipients in solid lipid nanoparticles☆
RADOMSKASOUKHAREV, A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.004 · Cited by 205
Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC
Souto, E. B., Mehnert, W., & Müller, R. H. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600612439 · Cited by 204
Saupe, A., Gordon, K. C., & Rades, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.022 · Cited by 199
Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations
Desai, P. P., Date, A. A., & Patravale, V. B. (2012) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2011.12.001 · Cited by 199
The influence of the crystallinity of lipid nanoparticles on their occlusive properties
Wissing, S. A., & Müller, R. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00220-x · Cited by 198
A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers
Li, X., Nie, S.-F., Kong, J., Li, N., Ju, C.-Y., & Pan, W.-S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.017 · Cited by 195
Balguri, S. P., Adelli, G. R., & Majumdar, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.015 · Cited by 195
Gartziandia, O., Herran, E., Pedraz, J. L., Carro, E., Igartua, M., & Hernandez, R. M. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.06.054 · Cited by 194
Sánchez-López, E., Espina, M., Doktorovova, S., Souto, E. B., & García, M. L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.013 · Cited by 185
Mendes, A. I., Silva, A. C., Catita, J. A. M., Cerqueira, F., Gabriel, C., & Lopes, C. M. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.05.041 · Cited by 181
Tsai, M.-J., Wu, P.-C., Huang, Y.-B., Chang, J.-S., Lin, C.-L., Tsai, Y.-H., & Fang, J.-Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.009 · Cited by 177
Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration
Gaba, B., Fazil, M., Ali, A., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2014.898110 · Cited by 174
Carbon nanotubes part II: a remarkable carrier for drug and gene delivery
Karimi, M., Solati, N., Ghasemi, A., Estiar, M. A., Hashemkhani, M., Kiani, P., Mohamed, E., Saeidi, A., Taheri, M., Avci, P., et al. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1004309 · Cited by 174
Olbrich, C., Kayser, O., & Müller, R. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00035-2 · Cited by 173
Araújo, J., Nikolic, S., Egea, M. A., Souto, E. B., & Garcia, M. L. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.06.025 · Cited by 171
Shete, H. K., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.034 · Cited by 170
Incorporation of cyclosporin A in solid lipid nanoparticles (SLN)
Ugazio, E., Cavalli, R., & Gasco, M. R. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00268-5 · Cited by 168
Abdel-Mottaleb, M. M. A., Neumann, D., & Lamprecht, A. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.009 · Cited by 167
Seyfoddin, A., & Al-Kassas, R. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.665460 · Cited by 164
Nanoparticulate drug delivery systems for cancer chemotherapy
Saha, R. N., Vasanthakumar, S., Bende, G., & Snehalatha, M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.510804 · Cited by 163
Self-citationCombination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
Fang, J. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s9155 · Cited by 159
Souto, E. B., & Müller, R. H. (2006) · Journal of Microencapsulation · doi:10.1080/02652040500435295 · Cited by 159
Optimization of artemether-loaded NLC for intranasal delivery using central composite design
Jain, K., Sood, S., & Gowthamarajan, K. (2015) · Drug Delivery · doi:10.3109/10717544.2014.885999 · Cited by 158
Cirri, M., Bragagni, M., Mennini, N., & Mura, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.015 · Cited by 155
Preservation of nanostructured lipid carriers (NLC)
Obeidat, W. M., Schwabe, K., Müller, R. H., & Keck, C. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.001 · Cited by 155
Tran, T. H., Ramasamy, T., Truong, D. H., Choi, H., Yong, C. S., & Kim, J. O. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0175-y · Cited by 153
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases
Cacciatore, I., Ciulla, M., Fornasari, E., Marinelli, L., & Di Stefano, A. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1178237 · Cited by 153
Zhang, T., Chen, J., Zhang, Y., Shen, Q., & Pan, W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.005 · Cited by 152
Electron microscopy of pharmaceutical systems
Klang, V., Valenta, C., & Matsko, N. B. (2012) · Micron · doi:10.1016/j.micron.2012.07.008 · Cited by 151
Shao, Z., Shao, J., Tan, B., Guan, S., Liu, Z., Zhao, Z., He, F., & Zhao, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s77837 · Cited by 151
Khan, A., Imam, S. S., Aqil, M., Ahad, A., Sultana, Y., Ali, A., & Khan, K. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00586 · Cited by 144
Ricci, M., Puglia, C., Bonina, F. P., Giovanni, C. D., Giovagnoli, S., & Rossi, C. R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20335 · Cited by 143
Jores, K., Haberland, A., Wartewig, S., Mäder, K., & Mehnert, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7148-5 · Cited by 142
Influence of high pressure homogenisation equipment on nanodispersions characteristics
Liedtke, S., Wissing, S. A., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00417-2 · Cited by 140
Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Körting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9225-9 · Cited by 140
Alam, T., Pandit, J., Vohora, D., Aqil, M., Ali, A., & Sultana, Y. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.945416 · Cited by 138
Pradhan, M., Singh, D., Murthy, S. N., & Singh, M. R. (2015) · Steroids · doi:10.1016/j.steroids.2015.05.012 · Cited by 125
Shen, J., Deng, Y., Jin, X., Ping, Q., Su, Z., & Li, L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.008 · Cited by 125
Neupane, Y. R., Srivastava, M., Ahmad, N., Kumar, N., Bhatnagar, A., & Kohli, K. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.001 · Cited by 124
Field-Flow Fractionation: Addressing the Nano Challenge
Williams, S. K. R., Runyon, J. R., & Ashames, A. (2010) · Analytical Chemistry · doi:10.1021/ac101759z · Cited by 124
Varshosaz, J., Eskandari, S., & Tabbakhian, M. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.01.051 · Cited by 123
Chen, Y., Pan, L., Jiang, M., Li, D., & Jin, L. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1049719 · Cited by 122
Optimizing SLN and NLC by 22 full factorial design: Effect of homogenization technique
Severino, P. B., Santana, M. H. A., & Souto, E. B. (2012) · Materials Science and Engineering C · doi:10.1016/j.msec.2012.04.017 · Cited by 122
Current Dendrimer Applications in Cancer Diagnosis and Therapy
Majoros, I., Williams, C., & Baker, J. R. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785849049 · Cited by 122
Thatipamula, R. P., Palem, C., Gannu, R., et al. (2011) · PubMed · Cited by 121
Varshosaz, J., Eskandari, S., Minaiyan, M., & Tabbakhian, M. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s15881 · Cited by 120
Development of risperidone liposomes for brain targeting through intranasal route
Narayan, R., Singh, M., Ranjan, O. P., Nayak, Y., Garg, S., Shavi, G. V., & Nayak, U. Y. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.033 · Cited by 118
Nanostructured lipid carriers for the topical delivery of tretinoin
Ghate, V., Lewis, S. A., Prabhu, P., Dubey, A., & Patel, N. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.026 · Cited by 116
Formulation and characterization of nanostructured lipid carriers containing a mixed lipids core
Zheng, M., Falkeborg, M. F., Zheng, Y. C., Yang, T., & Xu, X. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.03.070 · Cited by 115
Gainza, G., Celdran‐Bonafonte, D., Moreno, B., Aguirre, J. J., Gutiérrez, F. B., Villullas, S., Pedraz, J. L., Igartua, M., & Hernández, R. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.033 · Cited by 114
Tan, S. W., Billa, N., Roberts, C. J., & Burley, J. (2010) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2010.09.030 · Cited by 113
Singh, S. K., Dadhania, P., Vuddanda, P. R., Jain, A., Velaga, S., & Singh, S. (2016) · RSC Advances · doi:10.1039/c5ra19793g · Cited by 113
Song, S., Mao, G., Du, J., & Zhu, X. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1064186 · Cited by 112
Liu, R., Liu, Z., Zhang, C., & Zhang, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23251 · Cited by 111
Flow field-flow fractionation for the analysis of nanoparticles used in drug delivery
Zattoni, A., Roda, B., Borghi, F., Marassi, V., & Reschiglian, P. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.08.018 · Cited by 110
Formulation and delivery of itraconazole to the brain using a nanolipid carrier system
Lim, W., RAJINIKANTH, P. S., Mallikarjun, C., & KANG, Y. B. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s57565 · Cited by 103
Manea‐Saghin, A., Vasile, B. Ş., & Meghea, A. (2013) · Comptes Rendus Chimie · doi:10.1016/j.crci.2013.07.015 · Cited by 101
Ranpise, N. S., Korabu, S. S., & Ghodake, V. N. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.12.012 · Cited by 97
Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery
Wavikar, P. R., & Vavia, P. R. (2015) · Journal of Liposome Research · doi:10.3109/08982104.2014.954129 · Cited by 94
FA-loaded lipid drug delivery systems: Preparation, characterization and biological studies
Carbone, C., Campisi, A., Musumeci, T., Raciti, G., Bonfanti, R., & Puglisi, G. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.003 · Cited by 90
Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin
Shangguan, M., Lü, Y., Qi, J., Han, J., Tian, Z., Xie, Y., Hu, F., Yuan, H., & Wu, W. (2013) · Journal of Biomaterials Applications · doi:10.1177/0885328213485141 · Cited by 89
Fu, T., Yi, J., Lv, S., & Zhang, B. (2016) · Journal of Liposome Research · doi:10.1080/08982104.2016.1224899 · Cited by 88
Moreno-Sastre, M., Pastor, M., Esquisabel, A., Sans, E., Viñas, M., Fleischer, A., Palomino, E., Bachiller, D., & Pedraz, J. L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.028 · Cited by 87
Patil-Gadhe, A., Kyadarkunte, A., Patole, M., & Pokharkar, V. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.007 · Cited by 84
Khan, S., Yar, M. S., Fazil, M., Baboota, S., & Ali, J. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.017 · Cited by 84
Zhou, X., Zhang, X., Ye, Y., Zhang, T., Wang, H., Ma, Z., & Wu, B. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.068 · Cited by 78
Observation of Size-Dependent Melting in Lipid Nanoparticles
Unruh, T., Bunjes, H., Westesen, K., & Koch, M. H. J. (1999) · The Journal of Physical Chemistry B · doi:10.1021/jp9912612 · Cited by 75
Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method
Liu, D., Jiang, S., Shen, H., Qin, S., Liu, J., Zhang, Q., Li, R., & Xu, Q. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-9998-y · Cited by 75
Liu, R., Sun, L., Fang, S., Wang, S., Chen, J., Xiao, X., & Liu, C. (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2015.1026607 · Cited by 74
Fangueiro, J. F., Andreani, T., Egea, M. A., García, M. L., Souto, S. B., & Souto, E. B. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.04.014 · Cited by 73
Pastor, M., Moreno-Sastre, M., Esquisabel, A., Sans, E., Viñas, M., Bachiller, D., Asensio, V. J., del Pozo, Á., Gaínza, E., & Pedraz, J. L. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.048 · Cited by 71
Ruktanonchai, U., Limpakdee, S., MEEJOO, S., Sakulkhu, U., Bunyapraphatsara, N., Junyaprasert, V. B., & Puttipipatkhachorn, S. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/9/095701 · Cited by 59
Esposito, E., Ravani, L., Drechsler, M., Mariani, P., Contado, C., Ruokolainen, J., Ratano, P., Campolongo, P., Trezza, V., Nastruzzi, C., et al. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.12.012 · Cited by 58
Recent Trends in Clinical Trials Related to Carrier-Based Drugs
Tagami, T., & Ozeki, T. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.02.026 · Cited by 54
Cortesi, R., Valacchi, G., Mureșan, X. M., Drechsler, M., Contado, C., Esposito, E., Grandini, A., Guerrini, A., Forlani, G., & Sacchetti, G. (2017) · Journal of Microencapsulation · doi:10.1080/02652048.2017.1284276 · Cited by 49
Yu, S., Tan, G., Liu, D., Yang, X., & Pan, W. (2017) · RSC Advances · doi:10.1039/c7ra00552k · Cited by 48
Lacerda, S. D. P., Cerize, N. N. P., & Ré, M. I. (2011) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2010.00626.x · Cited by 45
Patil-Gadhe, A., & Pokharkar, V. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.080 · Cited by 45
Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells
Santos, S. G., Neves, A. R., da Silva, A. M., Barbosa, M. A., Reis, S., & Barbosa, J. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s108694 · Cited by 44
Characterization and Imaging of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
Üner, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15338-4_3 · Cited by 41
Tofani, R., SUMIRTAPURA, Y. C., & Darijanto, S. T. (2016) · Scientia Pharmaceutica · doi:10.3390/scipharm84040634 · Cited by 40
Zhao, J., Piao, X., Shi, X., Si, A., Zhang, Y., & Feng, N. (2016) · Molecules · doi:10.3390/molecules21111549 · Cited by 36
Handbook of Materials for Nanomedicine
Torchilin, V. P. (2010) · Pan Stanford eBooks · doi:10.1201/b11121 · Cited by 31
Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo
Tronino, D., Offerta, A., Ostacolo, C., Russo, R., Caro, C. D., Calignano, A., Puglia, C., & Blasi, P. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.058 · Cited by 28
Muchow, M., Muchow, M., Schmitz, E. I., Despatova, N., Maincent, P., & Müller, R. H. (2009) · Die Pharmazie · doi:10.31083/ph.2009.9084 · Cited by 26
Preparation and Characterization of 10-Hydroxycamptothecin Loaded Nanostructured Lipid Carriers
Liu, K., Sun, J., Wang, Y., He, Y., Gao, K., & He, Z. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701662230 · Cited by 25
Advances in Brain Targeted Drug Delivery: Nanoparticulate Systems
Joseph, E., & Saha, R. N. (2013) · Cited by 24
Self-citationPardeike, J., Weber, S., Matsko, N. B., & Zimmer, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.018 · Cited by 21
Cited by
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems
Mishra, V., Bansal, K. K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., & Rosenholm, J. M. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040191 · Cited by 669
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.10.017 · Cited by 569
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review
Haider, M., Abdin, S. M., Kamal, L., & Orive, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030288 · Cited by 451
Metadata
- Authors
- Khosa, A., Reddi, S., & Saha, R. N.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 103
- Pages
- 598-613
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2800752654
- Cited by
- 619
- References
- 161
- FWCI
- 17.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.